Exagen Shares Are Trading Higher After the Company Reported Better-than-expected Q2 Financial Results and Increased Its FY24 Revenue Outlook Above Estimates.
Exagen Shares Are Trading Higher After the Company Reported Better-than-expected Q2 Financial Results and Increased Its FY24 Revenue Outlook Above Estimates.
exagen股价上涨，公司报告Q2财务业绩优于预期并将FY24营业收入预期上调。
Exagen Shares Are Trading Higher After the Company Reported Better-than-expected Q2 Financial Results and Increased Its FY24 Revenue Outlook Above Estimates.
exagen股价上涨，公司报告Q2财务业绩优于预期并将FY24营业收入预期上调。